Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 17/20 | 0.44 |
| ▸ | MAOA | P21397 | 3/20 | 0.43 |
| ▸ | MAOB | P27338 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | CALML3 | P27482 | 1/20 | 0.42 |
| ▸ | SDHA | P31040 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6619924 | 0.83 | F10 (0.45) | F10MAOAMAOB | |
| SCHEMBL13428648 | 0.78 | F10 (0.66) | F10MAOAMAOBLMNAPTGS1 | |
| SCHEMBL5214903 | 0.78 | MAOA (0.47) | F10MAOAMAOBLMNAPTGS1 | |
| SCHEMBL12956275 | 0.76 | MAOA (0.55) | F10MAOAMAOBLMNAPTGS1 | |
| SCHEMBL5838600 | 0.75 | F10 (0.46) | F10MAOAMAOBLMNAPTGS1 | |
| SCHEMBL6487750 | 0.75 | F10 (0.49) | F10MAOAMAOBLMNAPTGS1 | |
| SCHEMBL1034798 | 0.75 | MAOA (0.54) | F10MAOAMAOBLMNAPTGS1 | |
| SCHEMBL1034799 | 0.75 | MAOA (0.54) | F10MAOAMAOBLMNAPTGS1 | |
| SCHEMBL5739169 | 0.74 | F10 (0.51) | F10MAOB | |
| SCHEMBL12956100 | 0.74 | MAOA (0.50) | F10MAOAMAOBLMNAPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7049443-B2 | Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound | PHARMACIA & UPJOHN COMPANY (US) | 2006-05-23 | — | — | US | disclosed |
| US-20040014967-A1 | Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound | PHARMACIA & UPJOHN COMPANY | 2004-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040014967-A1 | Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound | AADAC, AAAS, SLC7A1 | F10 2380/4885MAOA 1179/4885MAOB 732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.